Identify a novel approach to effectively mitigate levodopa-induced dyskinesias (LID) while maintaining motor benefits of Parkinson disease (PD) therapy (i.e., levodopa).
No takes yet. Share an insight, caveat, or question.
Caulfield et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: